SAFC Bags Two Mammalian Tech Contracts with Asian Biopharma Firms
SAFC says demand from Asian biologics firms keen to be first to market helped it win two contracts for its CHOZN production platform.
SAFC says demand from Asian biologics firms keen to be first to market helped it win two contracts for its CHOZN production platform.
Boehringer Ingelheim will build a biomanufacturing facility in Shanghai in a strategic alliance designed to cater for Pharmas nervous about setting up plants in China.